| Entry |
|
|---|
| Name |
Brivudine (INN);
Zostex (TN)
|
|---|
| Formula |
C11H13BrN2O5
|
|---|
| Exact mass |
332.0008
|
|---|
| Mol weight |
333.1353
|
|---|
| Structure |
     |
|---|
| Activity |
Antiviral
|
|---|
| Remark |
|
|---|
| Comment |
Thymidine analogue
|
|---|
| Target |
DNA polymerase inhibitor [EC: 2.7.7.7] |
|---|
| Structure map |
|
|---|
| Brite |
Anatomical Therapeutic Chemical (ATC) classification [BR:br08303]
J ANTIINFECTIVES FOR SYSTEMIC USE
J05 ANTIVIRALS FOR SYSTEMIC USE
J05A DIRECT ACTING ANTIVIRALS
J05AB Nucleosides and nucleotides excl. reverse transcriptase inhibitors
J05AB15 Brivudine
D07249 Brivudine (INN)
 |
|---|
| Other DBs |
CAS: 69304-47-8 PubChem: PDB-CCD: LigandBox: NIKKAJI: |
|---|
| KCF data |
ATOM 19
1 C1y C 25.6900 -28.5600
2 N4y N 27.0200 -28.1400
3 O2x O 24.5700 -27.6500
4 C1x C 25.2700 -29.8200
5 C8y C 28.0700 -28.9800
6 C8x C 27.3000 -26.7400
7 C1y C 23.4500 -28.4900
8 C1y C 23.8700 -29.8200
9 N4x N 29.4000 -28.5600
10 O5x O 27.8600 -30.3800
11 C8y C 28.6300 -26.2500
12 C1b C 22.1200 -28.0700
13 C8y C 29.6800 -27.1600
14 C2b C 28.8400 -24.8500
15 O1a O 21.0700 -29.0500
16 O5x O 30.9400 -26.6700
17 C2b C 30.1700 -24.4300
18 X Br 30.3100 -23.0300
19 O1a O 23.0300 -30.9400
BOND 20
1 2 5 1
2 2 6 1
3 3 7 1
4 4 8 1
5 5 9 1
6 5 10 2
7 6 11 2
8 7 12 1 #Up
9 9 13 1
10 11 14 1
11 12 15 1
12 13 16 2
13 7 8 1
14 11 13 1
15 14 17 2
16 1 2 1 #Up
17 17 18 1
18 1 3 1
19 1 4 1
20 8 19 1 #Down
|
|---|
